A5003482519- Heart Failure Treatment and Management
- Transplantation: Methods and Outcomes
- Trypanosoma species research and implications
- Cardiovascular Function and Risk Factors
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac pacing and defibrillation studies
- Cancer Treatment and Pharmacology
- Cardiac Ischemia and Reperfusion
- Public Health in Brazil
- Viral Infections and Immunology Research
- Cardiac Imaging and Diagnostics
- Cardiovascular and exercise physiology
- Research on Leishmaniasis Studies
- Medication Adherence and Compliance
- Health Systems, Economic Evaluations, Quality of Life
- Cardiomyopathy and Myosin Studies
- Heart Rate Variability and Autonomic Control
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Renal Transplantation Outcomes and Treatments
- Cardiac Structural Anomalies and Repair
- Cancer-related cognitive impairment studies
- Mechanical Circulatory Support Devices
- Autoimmune Neurological Disorders and Treatments
- Diagnosis and Treatment of Venous Diseases
- Chemotherapy-related skin toxicity
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2008-2024
Universidade de São Paulo
2005-2024
Universidad Complutense de Madrid
2023-2024
Instituto do Coração
2022
Universidade do Estado do Rio de Janeiro
2018
Hospital Universitario La Paz
2015
Hospital de Egas Moniz
2012
Centro Universitário das Faculdades Metropolitanas Unidas
2010
Hospital Universitário da Universidade de São Paulo
2007
Parte 1: Diretriz Brasileira de Insuficiencia Cardiaca Cronica […] e Aguda
// Vagner Oliveira-Carvalho Rigaud 1, 2 , Ludmila R.P. Ferreira 2, 3 Silvia M. Ayub-Ferreira 1 Mônica S. Ávila Sara M.G. Brandão Fátima D. Cruz Marília H.H. Santos Cecilia B.B.V. Marco S.L. Alves Victor Issa Guilherme V. Guimarães Edécio Cunha-Neto Edimar A. Bocchi Heart Failure Unit, Institute (InCor), Hospital das Clínicas da Faculdade de Medicina Universidade São Paulo (HC-FMUSP), Paulo, Brazil Laboratory of Immunology,...
The effectiveness of heart failure disease management programs in patients under cardiologists' care over long-term follow-up is not established.We investigated the effects a program with repetitive education and telephone monitoring on primary (combined death or unplanned first hospitalization quality-of-life changes) secondary end points (hospitalization, death, adherence). REMADHE [Repetitive Education Monitoring for ADherence Heart Failure] trial randomized, prospective, parallel...
Peculiar aspects of Chagas cardiomyopathy raise concerns about efficacy and safety sympathetic blockade. We studied the influence beta-blockers in patients with cardiomyopathy.We examined REMADHE trial grouped according to etiology (Chagas versus non-Chagas) beta-blocker therapy. Primary end point was all-cause mortality or heart transplantation. Altogether 456 were studied; 27 (5.9%) submitted transplantation 202 (44.3%) died. present 68 (14.9%) patients; they had lower body mass index...
Background Sudden death has been considered the main cause of in patients with Chagas heart disease. Nevertheless, this information comes from a period before introduction drugs that changed natural history failure. We sought to study mode failure caused by disease, comparing non-Chagas cardiomyopathy. Methods and results examined REMADHE trial grouped according etiology (Chagas vs non-Chagas) death. The primary end-point was all-cause, sudden mortality; 342 were analyzed 185 (54.1%) died....
// Mauro Rogério de Barros Wanderley Jr. 1 , Mônica Samuel Ávila Miguel Morita Fernandes-Silva 2 Fátima das Dores Cruz Sara Michelly Gonçalves Brandão Vagner Oliveira Carvalho Rigaud Ludhmila Abrahão Hajjar 3 4 Roberto Kalil Filho Edécio Cunha-Neto Edimar Alcides Bocchi and Silvia Moreira Ayub-Ferreira Heart Failure Department, Institute (InCor) do Hospital Clínicas da Faculdade Medicina Universidade São Paulo, Brazil...
OBJETIVO: Avaliar o efeito do bisoprolol sobre a capacidade de exercício e função ventricular em pacientes com insuficiência cardíaca. MÉTODOS: Foi feita análise das variáveis clínicas hemodinâmicas, da remodelamento ventricular, ergoespirometria cardíaca diferentes etiologias, antes após administração bisoprolol. RESULTADOS: Foram analisados 22 pacientes, dos quais 1 paciente não tolerou medicação 14 alcançaram meta estudo. A média idades foi 52 anos (36 64 anos), 9 eram sexo masculino 5...
Background. Chagas disease caused by Trypanosoma cruzi (T. cruzi) affects approximately six million individuals worldwide. Clinical manifestations are expected to occur due the parasite persistence and host immune response. Herein we investigated potential associations between IL1B, IL6, IL17A or IL18 polymorphism profiles cardiomyopathy T. parasitemia, as well impact of HIV infection on cardiopathy. Methods. 206 patients 90 control were analyzed. IL1B rs1143627 T>C, IL6 rs1800795 C>G,...
SUMMARY Background: The origin of dyspnea in chronic heart failure (HF) is multifactorial, and excessive ventilation thought to play a role inducing this symptom. Chemosensivity augmented HF, correlates with increased pulmonary (VE), an adverse prognostic marker. Despite blood levels natriuretic peptides clinical conditions associated dyspnea, their effect on VE chemoreceptor activity remains unexplored. Methods: We tested prospective, placebo‐controlled, three‐way cross‐over, double‐blind...
Heart failure (HF) is associated with resting increased peripheral and central chemosensitivity which may correlate an ventilatory response to exercise. However, its sensitivity in HF during exercise was never really reported.We tested if stimulation of chemoreceptors patients could modulate ventilatory, chronotropic, neurohormonal submaximal exercise.We investigated 15 7 control (C) comparing through three 6 minute walking tests conducted a treadmill : room air, hypoxia, hypercapnia (in...